A pill version of Novo Nordisk’s Ozempic failed to slow the progression of Alzheimer’s disease in a pair of trials. Naomi Kresge reports on Bloomberg Television (Source: Bloomberg)
www.bloomberg.com
#Novos #Ozempic #Pill #Fails #Slow #Alzheimers #Studies
Novo’s Ozempic Pill Fails to Slow Alzheimer’s in Studies
